Targeting shallow protein surfaces represents a major frontier in drug discovery, crucial for addressing historically 'undruggable' targets like those involved in protein-protein interactions.
Protein-protein interactions (PPIs), once dismissed as 'undruggable' due to their large, flat, and hydrophobic interfaces, are now being successfully targeted thanks to a paradigm shift in drug discovery.
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) has emerged as a powerful biophysical technique for studying protein structure and dynamics, providing critical insights into protein-ligand interactions that drive modern drug discovery.
This article provides a complete guide to the Protein-Ligand Interaction Profiler (PLIP), an essential open-source tool for detecting non-covalent interactions in structural biology.
This article provides a comprehensive guide to molecular docking for ligand pose prediction, a critical technique in structure-based drug design.
This article provides a thorough exploration of Molecular Mechanics Poisson-Boltzmann/Generalized Born Surface Area (MM-PBSA and MM-GBSA) methods for estimating binding free energies in structure-based drug design.
This article provides a comprehensive guide for researchers and drug development professionals on utilizing Surface Plasmon Resonance (SPR) to characterize protein-small molecule interactions.
This article provides a thorough exploration of Bio-Layer Interferometry (BLI), a powerful, label-free optical biosensing technology for real-time biomolecular interaction analysis.
This article explores LABind, a novel structure-based deep learning method that revolutionizes protein-ligand binding site prediction by explicitly incorporating ligand information.
This article provides a comprehensive overview of virtual screening (VS) for identifying protein-ligand binding sites, a cornerstone of modern computational drug discovery.